225 related articles for article (PubMed ID: 17853310)
1. Do utilization management controls for phototherapy increase the prescription of biologics?
Simpson GL; Yelverton CB; Rittenberg S; Feldman SR
J Dermatolog Treat; 2006; 17(6):359-61. PubMed ID: 17853310
[TBL] [Abstract][Full Text] [Related]
2. Would elimination of copayments for phototherapy decrease the cost of treating psoriasis with systemic biologics? A cost analysis.
Simpson JF; Yelverton CB; Balkrishnan R; Fleischer A; Lide W; Feldman SR
Manag Care Interface; 2006 Jun; 19(6):39-43. PubMed ID: 16892660
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis.
Yentzer BA; Yelverton CB; Simpson GL; Simpson JF; Hwang W; Balkrishnan R; Feldman SR
Dermatol Online J; 2009 Apr; 15(4):1. PubMed ID: 19450394
[TBL] [Abstract][Full Text] [Related]
4. Outcomes associated with the use of biologic agents in moderate to severe psoriasis.
Price J; Bhosle M; Feldman SR; Balkrishnan R
J Drugs Dermatol; 2007 Mar; 6(3):259-67. PubMed ID: 17373187
[TBL] [Abstract][Full Text] [Related]
5. Phototherapy, psoriasis, and the age of biologics.
Richard EG; Hönigsmann H
Photodermatol Photoimmunol Photomed; 2014 Feb; 30(1):3-7. PubMed ID: 24313462
[TBL] [Abstract][Full Text] [Related]
6. Home ultraviolet B phototherapy: a cost-effective option for severe psoriasis.
Yelverton CB; Kulkarni AS; Balkrishnan R; Feldman SR
Manag Care Interface; 2006 Jan; 19(1):33-6, 39. PubMed ID: 16453993
[TBL] [Abstract][Full Text] [Related]
7. Care of patients with psoriasis: an audit of U.K. services in secondary care.
Eedy DJ; Griffiths CE; Chalmers RJ; Ormerod AD; Smith CH; Barker JN; Potter J; Ingham J; Lowe D; Burge S
Br J Dermatol; 2009 Mar; 160(3):557-64. PubMed ID: 19120330
[TBL] [Abstract][Full Text] [Related]
8. Disease and treatment burden of psoriasis: examining the impact of biologics.
Raval K; Lofland JH; Waters H; Piech CT
J Drugs Dermatol; 2011 Feb; 10(2):189-96. PubMed ID: 21283925
[TBL] [Abstract][Full Text] [Related]
9. Systemic and light therapies for the management of childhood psoriasis: part II.
Cordoro KM
Skin Therapy Lett; 2008 May; 13(4):1-3. PubMed ID: 18648714
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of moderate-to-severe psoriasis treatment.
Miller DW; Feldman SR
Expert Opin Pharmacother; 2006 Feb; 7(2):157-67. PubMed ID: 16433581
[TBL] [Abstract][Full Text] [Related]
11. Management and costs of severe psoriasis: the role of new biologics.
Feldman SR; Pearce DJ
Expert Rev Pharmacoecon Outcomes Res; 2004 Oct; 4(5):573-9. PubMed ID: 19807550
[TBL] [Abstract][Full Text] [Related]
12. Insight into psoriasis management: commercial perspectives for the U.S. psoriasis market.
Tran B; Feldman SR
J Dermatolog Treat; 2011 Feb; 22(1):18-26. PubMed ID: 20528668
[TBL] [Abstract][Full Text] [Related]
13. Home ultraviolet B phototherapy for psoriasis: discrepancy between literature, guidelines, general opinions and actual use. Results of a literature review, a web search, and a questionnaire among dermatologists.
Koek MB; Buskens E; Bruijnzeel-Koomen CA; Sigurdsson V
Br J Dermatol; 2006 Apr; 154(4):701-11. PubMed ID: 16536814
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic Agents.
Ighani A; Partridge ACR; Shear NH; Lynde C; Gulliver WP; Sibbald C; Fleming P
J Cutan Med Surg; 2019; 23(2):204-221. PubMed ID: 30463416
[TBL] [Abstract][Full Text] [Related]
15. Trends in home phototherapy adoption in the US: monetary disincentives are only the tip of the iceberg.
Yentzer BA; Feldman SR
J Dermatolog Treat; 2011 Feb; 22(1):27-30. PubMed ID: 20524873
[TBL] [Abstract][Full Text] [Related]
16. Review of home phototherapy.
Rajpara AN; O'Neill JL; Nolan BV; Yentzer BA; Feldman SR
Dermatol Online J; 2010 Dec; 16(12):2. PubMed ID: 21199628
[TBL] [Abstract][Full Text] [Related]
17. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry.
Nast A; Reytan N; Rosumeck S; Erdmann R; Rzany B
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1337-42. PubMed ID: 18624864
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis of the face and flexures.
van de Kerkhof PC; Murphy GM; Austad J; Ljungberg A; Cambazard F; Duvold LB
J Dermatolog Treat; 2007; 18(6):351-60. PubMed ID: 17907013
[TBL] [Abstract][Full Text] [Related]
19. Phototherapy in dermatology: A call for action.
Lim HW; Silpa-archa N; Amadi U; Menter A; Van Voorhees AS; Lebwohl M
J Am Acad Dermatol; 2015 Jun; 72(6):1078-80. PubMed ID: 25981004
[TBL] [Abstract][Full Text] [Related]
20. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
Tzu J; Kerdel F
Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]